Cutler Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,000
Closed -$10K 2598
2023
Q4
$10K Buy
+5,000
New +$56.6K ﹤0.01% 2381
2023
Q3
Sell
-1,900
Closed -$1K 3920
2023
Q2
$1K Buy
+1,900
New +$17.6K ﹤0.01% 3245
2023
Q1
Sell
-61,900
Closed -$3K 4024
2022
Q4
$3K Buy
61,900
+7,300
+13% +$91K ﹤0.01% 3461
2022
Q3
$7K Buy
54,600
+10,400
+24% +$182K ﹤0.01% 3374
2022
Q2
$2K Sell
44,200
-3,600
-8% -$85.2K ﹤0.01% 4266
2022
Q1
$21K Buy
47,800
+45,200
+1,738% +$1.2M ﹤0.01% 3009
2021
Q4
$2K Buy
+2,600
New +$80.9K ﹤0.01% 4706
2021
Q2
Sell
-2,600
Closed -$2K 5839
2021
Q1
$2K Sell
2,600
-15,400
-86% -$474K ﹤0.01% 4904
2020
Q4
$9K Buy
18,000
+15,300
+567% +$467K ﹤0.01% 3258
2020
Q3
$3K Buy
+2,700
New +$68.4K ﹤0.01% 3807
2020
Q2
Sell
-33,300
Closed -$1K 4484
2020
Q1
$1K Buy
+33,300
New +$912K ﹤0.01% 3682
2019
Q1
Sell
-1,400
Closed -$2K 4206
2018
Q4
$2K Buy
+1,400
New +$45.8K ﹤0.01% 3341

Other funds holding ELAN

Cutler Group's ELAN Position: Q1 2024 in Review

Cutler Group increased its Elanco Animal Health (ELAN) stake by 6.2% in Q1 2024, buying an estimated $2.99K and bringing the position to 3,295 shares worth $53K. The position accounts for 0.02% of the portfolio, ranked #642.

Cutler Group first reported a position in ELAN in Q4 2018 and has held it in 19 quarters since. The position peaked at $380K in Q4 2020. 375 funds tracked by Wall St. Rank hold ELAN as of Q1 2024.

  • Cutler Group held 3,295 shares of Elanco Animal Health worth $53K as of Q1 2024.
  • Cutler Group bought 191 Elanco Animal Health shares in Q1 2024, an estimated $2.99K.
  • Elanco Animal Health made up 0.02% of Cutler Group's portfolio in Q1 2024, its #642 holding.
  • Cutler Group first reported a position in Elanco Animal Health in Q4 2018 and has held it in 19 quarters since.
  • Cutler Group's Elanco Animal Health position peaked at $380K in Q4 2020.
  • 375 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.